8700 have signed this petition in a few days. #MedTwitter please sign and advocate to end ABIM MOC. We need to reach 10,000 signatures by tomorrow. @AaronGoodman33 chng.it/V4QkRbkJMb

Sharing our consensus on this important topic Blood Cancer Journal Sagar Lonial MD marivi mateos : Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: con… pubmed.ncbi.nlm.nih.gov/37528088/

Check out the recent paper on clinical efficacy and safety of CAR-T therapy for mantle cell lymphoma with secondary CNS involvement Christine Ryan, MD British Journal of Haematology onlinelibrary.wiley.com/doi/10.1111/bj…

A comprehensive 5★ perspective/review on cancer as a complex, systemic disease with all the hallmarks cell.com/cell/fulltext/… Cell by Charles Swanton and colleagues

Applying for Heme/onc fellowship? Consider our four year program w BMC|BU Geriatrics Fellowship results in triple board eligibility. It is designed to create leaders in the growing field of geriatric oncology. bumc.bu.edu/hematology/edu… Ryan Chippendale MD Maya Abdallah

Dr. Vaishali Sanchorawala presented the Skinner Awards to exceptional women scientists at the International Symposium on Amylodosis in Rochester, MN. Congratulations to Dr. Gunilla Westermark and Dr. Laura Obici! It was an honor to have Dr. Skinner at the inaugural ceremony.

As the event comes to a close, we want to express our gratitude to our dedicated multidisciplinary team members for sharing their research during the conference. #ISA2024 #Amyloidosis The International Society Of Amyloidosis

I’m excited to share that my latest review article on AL amyloidosis is now published in the New England Journal of Medicine! BU Amyloidosis Center Boston U Chobanian & Avedisian School of Medicine Boston Medical Center Systemic Light Chain Amyloidosis | New England Journal of Medicine nejm.org/doi/pdf/10.105…

I am deeply moved to announce that my review article on AL amyloidosis is published in the NEJM on June 27. This date marks the death anniversary of my mentor, Dr. David Seldin, whose guidance was instrumental in my journey. BU Amyloidosis Center nejm.org/doi/full/10.10…

The show to end #Biden2024 has started. #DebateNight

BU Amyloidosis Center

Key points: · AL amyloidosis is a plasma cell disorder, misfolded light chains depositing as fibrils in organs. · Signs & symptoms vary. · Novel treatments offer a better outlook. Systemic Light Chain Amyloidosis | New England Journal of Medicine nejm.org/doi/full/10.10…

Early diagnosis, increased awareness and effective treatments improve outcomes. Future focus - unmet clinical needs, development of patient centric clinical trials & engaging all stakeholders BU Amyloidosis Center Systemic Light Chain Amyloidosis pubmed.ncbi.nlm.nih.gov/38924733/

BU and BMC’s Vaishali Sanchorawala, MD, is leading a new study along with the Dana-Farber Cancer Institute for people with advanced stages of AL amyloidosis in Boston. To read more from the Boston Globe, click here: bit.ly/3Ymg8QK

Just out Blood Journal : Outcome of #CART therapy for #burkitt #lymphoma. Another great internatioal collaboration led by Laura Samples, MD Fred Hutch Cancer Center UW Medicine Newsroom ashpublications.org/blood/article-…

How I see the possible paths for transitioning from the Islamic Republic👇 After 40+ yrs of repression, the people of Iran are not just demanding freedom, they’re demanding JUSTICE, not someday, NOW Each path comes with a cost. What would you choose? #iranisraelwar #IranIsrael

⁉️ Why Are So Many Cancer Patients Turning to "Non-Standard" Therapies? ⁉️ What Does That Say About the Health Care System? A growing number of cancer patients are turning to non-standard therapies like ivermectin, fenbendazole, high-dose vitamin C, and mistletoe extract. Some